Benlysta could hit the markets late this year or in early 2011.
-
The GlaxoSmithKline pharmaceutical plan where Benlysta is being developed. -
The symptoms of Systemic Lupus Erythematosus. -
Benlysta could hit the markets late this year or in early 2011.
